The upper bound of a @ % confidence interval for the difference in prevalence of Stage @ and @ HTN between study arms indicates that discontinuation of study medication is unlikely to be associated with an increase in Stage @ HTN of > @ percentage points and in Stage @ HTN of no > @ percentage points .